Skip to main content
NOTE: Terms of Service Updated 21 Feb 2018

Slowing Down Memory Loss in Alzheimer's Disease

  • Published: 2013-11-15 : University of Houston.
  • Synopsis: Research looks at nerve cells in the hippocampus the part of the brain important for memory function and formation and one of the first regions affected by Alzheimers disease.

Main Document

Quote: "One of the major pathological hallmarks of Alzheimer's disease is the progressive accumulation of Abeta proteins in the brain, and this accumulation disrupts nerve cell function"

UH Researchers Working to Slow Down Memory Loss in Alzheimer's - Supported by $100K Alzheimer's Association Grant, Initial Results Published in PLoS.

Seeking to pinpoint Alzheimer's disease at its earliest manifestations, researchers at the University of Houston (UH) are working toward ways to slow down memory loss that would allow patients to better cope with this devastating disease.

By looking for the earliest breakdown of nerve cells in the brain, UH neuroscientist Jokubas Ziburkus and his team hope to restore nerve cell function in the early stages of Alzheimer's disease, ultimately correcting the dysfunction with new therapeutic targets. Ziburkus, whose research is supported by a $100,000 New Investigator Grant from the Alzheimer's Association, is collaborating with UH pharmacologist Jason Eriksen. Their results were recently published in PLoS ONE, an open access peer-reviewed scientific journal published by the Public Library of Science.

Ziburkus, an assistant professor of biology and biochemistry at UH, first became interested in the relationship between epilepsy and Alzheimer's. He was particularly struck by research suggesting that a much higher number of Alzheimer's patients than previously thought suffered from seizures. After more investigation, he says he was amazed by the lack of functional electrophysiological studies in Alzheimer's models. As an electro-physiologist, he saw a need and an opportunity and decided to apply his expertise in epilepsy research to study functional alterations in Alzheimer's.

He began collaborating with Eriksen, an assistant professor of pharmacology at UH. Together, they found a novel dysfunction in Alzheimer's disease that they anticipate will lead them to new, unexplored, potentially therapeutic interventions.

Their research looks at nerve cells in the hippocampus, which is the part of the brain important for memory function and formation, as well as one of the first regions affected by Alzheimer's disease. In particular, they are looking at amyloid-beta (Abeta), a protein fragment linked to Alzheimer's disease that accumulates in the hippocampus during early stages of the disease and is believed to cause dysfunction in this region.

"One of the major pathological hallmarks of Alzheimer's disease is the progressive accumulation of Abeta proteins in the brain, and this accumulation disrupts nerve cell function," Ziburkus said. "Using a rare combination of fast, functional imaging and challenging electrophysiological recordings, we discovered dysfunctional neural circuit activity and a severe inability of inhibitory neurons to produce electrical impulses in the hippocampus. Our new data suggests that the processing of information is greatly impaired or lost because of disruptions in specific cells and circuits in the hippocampus, potentially resulting in a failure to properly encode new memories. We seek to further identify the early onset of these functional changes in the cells and brain circuits key for memory formation. This work will provide new mechanistic insights into the early cell and network dysfunctions involved in dementia."

To do this, Ziburkus says they needed to understand how neural networks function, approximating activities of almost every individual neuron. The team's approach was to monitor activity in individual neurons and neuronal circuits, to get a better understanding of the mechanisms underlying dementia. Using electro-physiology, they were able to record a specific subset of neurons, called inhibitory cells, in the hippocampus. They also performed imaging experiments using voltage-sensitive dye, which is made up of fluorescent molecules that can report changes in electrical potential of individual neurons and neural circuits.

Through these electrical recordings of nerve cell activity, they focused on a region of the hippocampus known as the dentate gyrus thought to contribute to the formation of new memories. They found that the main type of excitatory cells in this region had unusually strong responses to signals from other neurons. The researchers believe this is caused by dysfunction in the nerve cells that normally inhibit such activity. Subsequently, they found impaired mechanisms believed to underlie short-term memory and activity that exhibited epileptic-like characteristics.

"For now, our work is revealing a new understanding of functional alterations in neurons and nerve cell networks that may underlie some of the pathology of Alzheimer's disease, such as memory loss and seizures," Ziburkus said. "These new mechanisms can lead us to a better understanding of the early dysfunctions in dementia through identification of new cellular mechanisms and effective ways of controlling nerve cell activity. Our ultimate hope is that this will lead to novel therapeutic approaches to treating the disease."

A testament to the success of their collaboration is the joint paper in PLoS ONE, which included four UH student authors who contributed significantly to various experimental and analytical aspects of the studies. Led by senior co-authors Ziburkus and Eriksen, the student contributors were recent Ph.D. graduates Anupam Hazra and Feng Gu and recent B.S. graduates Ahmad Aulakh and Casey Berridge.

An abstract of the paper, titled "Inhibitory Neuron and Hippocampal Circuit Dysfunction in an Aged Mouse Model of Alzheimer's Disease," can be found at www.ncbi.nlm.nih.gov/pubmed/23691195

Similar Topics

1 : Probiotics Improve Memory in People with Alzheimers Disease : Alzheimer's Research UK.
2 : Early Signs of Alzheimer's Disease - World's Most in Depth Study : .
3 : Is Alzheimer's an Autoimmune Disease - Study Shows Support it Could Be : Medical College of Georgia at Georgia Regents University.
4 : Vitamin D and Alzheimer's Disease : Thomas C. Weiss.
5 : Slowing Down Memory Loss in Alzheimer's Disease : University of Houston.
From our Alzheimer's Disease section - Full List (57 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : Early Childhood Education Requires Overhaul to Make it Accessible and Affordable
2 : How the Human Brain Can Tell Our Arms and Legs Apart
3 : Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease
4 : Palliative Care Findings on Caregiver Depression, LGBT Partners, Moral Distress

Citation


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.